Use UniProt P14646 as the stable identity anchor, then attach disease evidence before program review.
CHEMBL3382 Target Snapshot
3',5'-cyclic-AMP phosphodiesterase 4B · SINGLE PROTEIN · Rattus norvegicus
Research home keeps recent targets
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Switch target
Move to another high-traffic target or paste a specific ChEMBL target ID.
Frame the target before identity details
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-14Protein identity stays anchored to UniProt P14646. Use UniProt P14646 as the stable identity anchor, then attach disease evidence before program review.
3',5'-cyclic-AMP phosphodiesterase 4B
Review this target as 3',5'-cyclic-AMP phosphodiesterase 4B, mapped to UniProt P14646. Sequence length is 736 aa.
Protein source · UniProt accession via ChEMBL component mappingCross-source identity
Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats 3',5'-cyclic-AMP phosphodiesterase 4B as ChEMBL target CHEMBL3382, mapped to UniProt P14646. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Start with the right source
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether 3',5'-cyclic-AMP phosphodiesterase 4B is the right protein anchor across sources, using UniProt P14646 as the stable mapping.
Jump to Protein ContextUse this block first when you need the strongest disease program and evidence level in one place.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardBasic Information
Verify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | 3',5'-cyclic-AMP phosphodiesterase 4B |
| Target Type | SINGLE PROTEIN |
| Organism | Rattus norvegicus |
| UniProt | P14646 |
Next Actions
UniProt Target Context
Reviewable protein naming and mapping context for this target snapshot.
| Protein Label | 3',5'-cyclic-AMP phosphodiesterase 4B |
| UniProt Accession | P14646 |
| Component Type | Protein |
| Sequence Length | 736 aa |
3',5'-cyclic-AMP phosphodiesterase 4B
How to read this target
Review this target as 3',5'-cyclic-AMP phosphodiesterase 4B, mapped to UniProt P14646. Sequence length is 736 aa.
Clinical Phase Distribution
Activity Type Distribution
Top Inhibitors (by pChEMBL)
| ChEMBL ID | pChEMBL | Type | Value (nM) | Phase |
|---|---|---|---|---|
| CHEMBL3288029 | 10.7 | IC50 | 0.01995 | Preclinical |
| CHEMBL3288030 | 10.6 | IC50 | 0.02512 | Preclinical |
| CHEMBL97817 | 7.6 | IC50 | 25.0 | Preclinical |
| CHEMBL161115 | 7.35 | IC50 | 45.0 | Preclinical |
| CHEMBL74078 | 7.31 | IC50 | 49.0 | Preclinical |
| CHEMBL97214 | 7.16 | IC50 | 70.0 | Preclinical |
| CHEMBL98662 | 7.1 | IC50 | 80.0 | Preclinical |
| CHEMBL351613 | 7.09 | IC50 | 81.0 | Preclinical |
| CHEMBL161740 | 7.07 | IC50 | 85.0 | Preclinical |
| CHEMBL161465 | 6.96 | IC50 | 110.0 | Preclinical |
pChEMBL Value Distribution
Assay Landscape
Binding — 5 assays, 36 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| single protein format | 3 | 20 | 6.6 |
| assay format | 1 | 16 | 6.4 |
| cell-based format | 1 | 0 | — |